China NMPA Drug Inspection - Guangxi Yulin Huaantang Traditional Chinese Medicine Pieces Co., Ltd. - Rhodiola rosea
China NMPA drug inspection for Guangxi Yulin Huaantang Traditional Chinese Medicine Pieces Co., Ltd. published August 20, 2020. Drug: Rhodiola rosea. The National Medical Products Administration (NMPA) issued an announcement on August 20, 2020, detailing findings from d
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guangxi Yulin Huaantang Traditional Chinese Medicine Pieces Co., Ltd. published August 20, 2020. Drug: Rhodiola rosea. The National Medical Products Administration (NMPA) issued an announcement on August 20, 2020, detailing findings from d
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox